Please sign in to follow a disease.
Pulmonary sarcoidosis
MONDO:0001708Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Also known as: lung sarcoidosis, sarcoidosis of lung
89 clinical trials for this condition and its sub-types, 20 tagged with Pulmonary sarcoidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowThis study tests if hydroxychloroquine, a drug used for malaria and autoimmune diseases, can help people with sarcoidosis reduce or stop taking steroids. Sarcoidosis causes inflammation, often in the lungs, but this trial focuses on cases affecting the skin, eyes, or bones. 140 a…
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could tame lung inflammation in sarcoidosis
Disease control Recruiting nowThis Phase 2 trial tests OATD-01, an oral drug that blocks a protein called chitinase-1, in 96 people with active pulmonary sarcoidosis. Participants take the drug or a placebo for 12 weeks to see if it reduces lung inflammation measured by PET scans. The goal is to find a new tr…
Phase 2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for sarcoidosis patients: drug aims to tame lung inflammation and cut steroids
Disease control Recruiting nowThis study tests an experimental drug called XTMAB-16 in adults with pulmonary sarcoidosis, a condition causing lung inflammation. The goal is to see if the drug is safe and can help patients reduce or stop taking steroids, which have serious side effects. About 94 participants w…
Phase 1/2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a poop pill tame inflammation? new trial tests FMT for arthritis and bowel disease
Disease control Recruiting nowThis study tests whether fecal microbiota transplants (FMT) given as capsules can safely improve symptoms in people newly diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, or ulcerative colitis. Two hundred participants will receiv…
Phase 2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Weight loss drug ozempic tested in lung disease patients
Symptom relief Recruiting nowThis pilot study tests whether semaglutide (Ozempic), a drug used for diabetes and obesity, is safe and tolerable for weight loss in people with advanced lung disease. Eight participants with conditions like COPD or pulmonary fibrosis will take weekly injections for 12 weeks. Res…
Phase 1/2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for lung disease genes in 3,500 volunteers
Knowledge-focused Recruiting nowThis study looks at how genes play a role in lung diseases like cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will examine DNA from up to 3,500 people with and without lung disease to find genetic differences. The goal is to better understand what causes these cond…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study aims to predict lung outcomes in sarcoidosis patients
Knowledge-focused Recruiting nowThis study is developing prediction models to forecast lung function changes in people with sarcoidosis, a condition that causes inflammation in the lungs. Researchers will collect clinical data and blood markers from 200 adults during routine clinic visits. The goal is to create…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC